000 01604 a2200469 4500
005 20250518010815.0
264 0 _c20190415
008 201904s 0 0 eng d
022 _a1879-0712
024 7 _a10.1016/j.ejphar.2018.11.023
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJain, Mukul
245 0 0 _aPharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cJan 2019
300 _a113-120 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnemia
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aDown-Regulation
650 0 4 _aErythropoiesis
_xdrug effects
650 0 4 _aErythropoietin
_xblood
650 0 4 _aFemale
650 0 4 _aHepcidins
_xblood
650 0 4 _aInflammation
_xcomplications
650 0 4 _aIron
_xmetabolism
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice, Inbred BALB C
650 0 4 _aProlyl-Hydroxylase Inhibitors
_xpharmacology
650 0 4 _aQuinolones
_xpharmacology
650 0 4 _aRats, Inbred Lew
650 0 4 _aReticulocyte Count
700 1 _aJoharapurkar, Amit
700 1 _aPatel, Vishal
700 1 _aKshirsagar, Samadhan
700 1 _aSutariya, Brijesh
700 1 _aPatel, Maulik
700 1 _aPatel, Hiren
700 1 _aPatel, Pankaj R
773 0 _tEuropean journal of pharmacology
_gvol. 843
_gp. 113-120
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2018.11.023
_zAvailable from publisher's website
999 _c29072846
_d29072846